SCIENTIFIC PROGRAMME
SESSION I
HOW I TREAT
SMOLDERING MYELOMA
(SMM)
SESSION II
HOW I TREAT NEWLY
DIAGNOSED MULTIPLE
MYELOMA
SESSION III
FROM RISK
STRATIFICATION TO
RISK-BASED THERAPY?
DEBATE 1
SHOULD WE USE MRD
TESTING TO DETERMINE
THERAPY IN MULTIPLE
MYELOMA?
DEBATE 2
IS THERE A FUTURE ROLE
OF AUTOLOGOUS STEM
CELL TRANSPLANTATION?
SESSION IV
HOW I TREAT RELAPSED
MULTIPLE MYELOMA
DEBATE 3
SHOULD EVERY PATIENT
RECEIVE DARATUMUMAB
IN FIRST LINE?
ROUNDTABLE
MULTIPLE MYELOMA
FROM THE PERSPECTIVE
OF FDA/EMEA AND
FOUNDATIONS
SESSION V
YOU CAN’T BE IMMUNE
FOR IMMUNE THERAPY
ANYMORE
SESSION VI
OTHER PLASMA CELL
DYSCRASIAS
KEYNOTE LECTURES
THE FUTURE OF
MULTIPLE MYELOMA
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
ABSTRACTS SELECTED
AS POSTERS
DISCLOSURES
Poster 23: GALECTIN-3 AS A MARKER OF KIDNEY DAMAGE IN MONOCLONAL
GAMMOPATHY OF UNSPECIFIED VALUE AND MULTIPLE MYELOMA IN
RESIDENTS OF GOMEL REGION OF BELARUS
Zhanna Kozich, Victor Martinkov, Janna Pugacheva, Dzmitry Blizin and Ludmila
Smirnova
Poster 24: MULTIPLE MYELOMA ASSOCIATED WITH TYPE I CRYOGLOBULINEMIC
VASCULITIS: A CASE REPORT
Bhavya S Kumar and Geetha Narayanan
Poster 25: ABDOMINAL PLASMOCYTOMA: CASE REPORT OF A RARE MISLEADING
DISEASE
Gianfranco Lapietra, Francesca Fazio, Mattia Brescini and Maria Teresa Petrucci
Poster 26: A RARE CASE OF ISOLATED CENTRAL NERVOUS SYSTEM (CNS) RELAPSE OF
MULTIPLE MYELOMA (MM)
Natasa Eleni Loutsidi, Natali El Gkotmi, Konstantinos Kaouranis, Evagelia Kyriaki
Dimitraki, Anna Roumelioti, Themistoklis Karmiris and Sosanna Delimpasi
Poster 27: COMPLICATIONS AND ASSOCIATIONS IN A MULTIPLE MYELOMA COHORT AT
PRESENTATION
Anazoeze Jude Madu, Kenechi Madu, Angela Ugwu, Kelechi Chikezie, Collins
Maduka and Onochie Obodo
Poster 28: A GIANT PELVIC MASS IN A MULTIPLE MYELOMA PATIENT
Bárbara Marques, João Gaião, Catarina Nora, Adriana Roque, Raquel Guilherme, Marta
Pereira, Luís Francisco, Catarina Geraldes and Letícia Ribeiro
Poster 29: DEPTH OF RESPONSE AND RESPONSE KINETICS OF ISATUXIMAB PLUS
CARFILZOMIB AND DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA:
IKEMA INTERIM ANALYSIS
Thomas Martin, Joseph Mikhael, Roman Hajek, Kihyun Kim, Kenshi Suzuki, Cyrille Hulin,
Mamta Garg, Hang Quach, Hanlon Sia, Anup George, Tatiana Konstantinova, Marie-
Laure Risse, Gaelle Asset, Sandrine Macé, Helgi van de Velde and Philippe Moreau
Poster 30: ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN THE CARTITUDE-1
STUDY OF CILTACABTAGENE AUTOLEUCEL IN RELAPSED/REFRACTORY
MULTIPLE MYELOMA
Thomas Martin, Yi Lin, Mounzer Agha, Adam D. Cohen, Myo Htut, A Keith Stewart,
Parameswaran Hari, Jesus G. Berdeja, Deepu Madduri, Saad Z. Usmani, Tzu-Min Yeh,
Alicia J. Allred, Yunsi Olyslager, Arnob Banerjee, Jenna D. Goldberg, Jordan M. Schecter,
Carolyn C. Jackson, William Deraedt, Katharine S. Gries, John Fastenau, Xiaoling Wu,
Marlene J. Carrasco-Alfonso, Muhammad Akram, Farah Hossain, Andrzej
Jakubowiak and Sundar Jagannath
Poster 31: IG D MULTIPLE MYELOMA – A REVIEW OF 6 CASES FROM A SINGLE CENTRE.
Dr. Abhilash Menon, Dr. Geetha Narayanan, Dr. Sreejith Nair, Dr. Prakash N P, Dr.
Sugeeth MT and Dr. Jayasudha A V